Fwd: ICRS 2025: Call for Late-Breaking Abstracts – Deadline April 30!
PROF DR EFFAT OMAR @ ABDUL RAHMAN
From: WAN YONG HO <WanYo...@nottingham.edu.my>
Date: Fri, Apr 11, 2025 at 1:06 PM
Subject: ICRS 2025: Call for Late-Breaking Abstracts – Deadline April 30!
To: ef...@uitm.edu.my <ef...@uitm.edu.my>
Cc: Nor Hayati Othman <haya...@usm.my>, pavitra tha <pavit...@hotmail.com>
Dear Prof. Effat,
Greetings from the International Cancer Research Symposium (ICRS) 2025.
I’m excited to share the latest speaker highlights and some exciting updates from the symposium!
Please help us spread the word by forwarding this information to your colleagues and network who may be interested.
Thank you for your support, and we look forward to welcoming you and your professional contacts to this prestigious event.
Warm regards,
Wan Yong Ho
Associate Professor (PhD), PGCHE, Fellow of HEA (UK)
Chair
ICRS2025 Organising & Scientific Commitee
|
|
|
International Cancer Research Symposium 2025 Bridging Borders: Addressing Cancer Across South-East Asia 14 - 15 May, 2025 | The Waterfront Hotel Kuching | Sarawak, Malaysia |
|
Dear YBhg. Dato'/ Datuk/ Datin/ Professor/ Assoc. Prof/ Dr/ Mr/ Mdm/ Ms,
We’re excited to announce that participation in the International Cancer Research Symposium 2025 is now eligible for 16 Medical Specialist CPD points!
Missed the March deadline? No worries—there’s still time! You can submit your Late-Breaking Abstract until 30 April 2025 and showcase your latest research in cancer and pathology.
This is your final opportunity to:
Don't miss the chance to learn from top experts in the field—check out our featured list of distinguished speakers below!
Help us amplify innovation—forward this to colleagues who shouldn’t miss this chance! |
|
Important Deadlines Announcement |
|
Late Breaking Abstract (Poster presentation only) Submission: by 30 April 2025 Abstract Acceptance Notification: by 5 May 2025 Early Bird Registration: by 30 April 2025 Early Bird Payment: by 7 May 2025 Normal/On-site Registration: From 1 May 2025 onwards
🔗 Submit Your Abstract Now: https://bit.ly/ICRS2025AbstractSubmission |
|
|
Event Highlights |
||||||
|
Conference Proceedings Publications: Accepted abstracts will be published in the conference proceedings in the Asia-Pacific Journal of Clinical Oncology (APJCO). Selected abstracts are welcomed to submit full papers to be published in APJCO. |
|
||||||
|
|||||||
|
Young Researchers Highlights:
- Student Ambassador Programme (Details available upon registration) |
Save 50% on registration as a Student Ambassador! |
||||||
|
Theme Speakers Highlight |
|
Prof Cheong Sok Ching
|
Professor Cheong is the Chief Scientific Officer at Cancer Research Malaysia. She is also an Adjunct Professor at the Faculty of Dentistry, University of Malaya. Her work aims to improve management and survival of cancer patients through the understanding of the underlying molecular changes, and through the development of novel treatment approaches, focusing on head and neck cancers. Her work includes the development of immunotherapy and the use CRISPR-Cas9 essential screens to identify novel targets for head and neck cancer. In addition, she also focuses on early detection using innovative strategies including the development of novel mobile health tools such as MeMoSA®, enabling early detection of oral cancer. She has received grants from national and international funding bodies including the Newton-Ungku Omar Fund, Newton Fund Impact Scheme, Global Challenges Research Fund and the Ministry of Science, Technology and Innovation SMART Fund, amongst others. In recognition of her research contributions, she has received several national and international scientific awards, including the President’s Award by the International Association of Oral Maxillofacial Pathologist (IAOP), the 8th Underwriters Laboratories-ASEAN-US Science Prize for Women 2022 and The World Academy of Sciences (TWAS) Medal Lecture. |
|
Theme talk: Leveraging technology for oral cancer detection |
|
Dr. Teck Yew Low
Universiti Kebangsaan Malaysia (UKM) |
Dr. Teck Yew Low is an Associate Professor and Senior Research Fellow at the UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM). He holds a PhD in Biochemistry from the National University of Singapore and a BSc (Hons) in Biotechnology from Imperial College London. He completed his post-doctoral training at the Center for Experimental Bioinformatics (CEBI) in Denmark and the Netherlands Proteomics Center (NPC) in Utrecht University. Dr. Low has over 20 years of experience in proteomics and biological mass spectrometry, with research interests in cancer proteogenomics, phosphoproteomics, and drug-protein interactions. Dr. Low is actively involved in the proteomics community, serving as Secretary General of the Asia Oceania Human Proteome Organization (AOHUPO) and President of the Malaysian Proteomics Society (MAPS). He is Editor-in-Chief of Proteome Science and a member of the Editorial Board for Molecular & Cellular Proteomics (MCP). Dr. Low frequently shares his work at conferences and events, including the piHUB Global Summit and CNHUPO Congress, contributing to the advancement of proteomics research and collaboration. |
|
Unveiling the Coding Potential of Unannotated Short ORFs in Disease: Comprehensive Identification and Quantification of Microproteins Across Multiple Stages of Colorectal Cancer (CRC) |
|
Dr Susanti Susanti
|
Dr. Susanti is a trained pharmacist graduated from Universitas Gadjah Mada in Jogjakarta, Indonesia. She obtained a M. Phil from The John Curtin School of Medical Research at the Australian National University in Canberra, Australia. She finished her PhD in Molecular Pathology Group, School of Medicine, University of Nottingham. She then continued doing research in the same group in Nottingham as a Postdoctoral Research Fellow. She is now a researcher in Cancer Research UK Beatson Institute in Glasgow, under mentorship of Prof. Owen Sansom. Her current research focuses on stem cell niche in early progression of colorectal cancer and biological mechanism of early onset colorectal cancer. In early 2021, She combined her scientific knowledge and skills with her personal experience as cancer survivor to found PathGen Diagnostic Technology, a start-up which focuses on utilising low-cost technology for molecular genotyping to guide the care of cancer (and other diseases) in resource-limited countries such as Indonesia. She has won numerous awards including Vice Chancelor Award from University of Nottingham, Innovator Award for Pharmaceutical and Medical Device 2022 from Indonesia Ministry of Health and Early Career Entrepreneur of the Year 2022 from Cancer Research Horizon UK. |
|
Pathology Workshop: Molecular testing for Colorectal Cancer in the East |
|
|
|
|
|
|
Stay tuned for more e-mail updates or visit our website for the latest updates!
Co-organised by
|
||
|
Supported by
|
|
ICRS 2025 14 - 15 May, 2025 | The Waterfront Hotel Kuching | Sarawak, Malaysia
For more information, visit https://www.nottingham.edu.my/Conferences/ICRS2025/index.aspx |
PENAFIAN: E-mel ini dan apa-apa fail yang dihantar bersama-samanya ("Mesej") adalah dihasratkan hanya untuk kegunaan penerima yang dinyatakan di atas dan mungkin mengandungi maklumat yang tidak umum, bermilik, istimewa, sulit dan dikecualikan dari penzahiran di bawah undang-undang yang terpakai termasuklah Akta Rahsia Rasmi 1972. BACA SELANJUTNYA...
DISCLAIMER : This e-mail and any files transmitted with it ("Message") is intended only for the use of the recipient(s) named above and may contain information that is non-public, proprietary, privileged, confidential and exempt from disclosure under applicable law including the Official Secrets Act 1972. READ MORE...